Previous Close | 2.0150 |
Open | 1.9900 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 1.9900 - 1.9900 |
52 Week Range | 1.2000 - 2.9900 |
Volume | |
Avg. Volume | 23,448 |
Market Cap | 216.564M |
Beta (5Y Monthly) | 0.62 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0460 |
Earnings Date | Jul 14, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Subscribe to Yahoo Finance Plus to view Fair Value for OPSSF
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF) a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, today released results for its third quarter ended May 31, 2022.
OpSens Inc.. ("OpSens" or the "Company") (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology has been awarded a national group purchasing agreement for Interventional Specialty Diagnostics with Premier, Inc. (Premier), a leading healthcare improvement company uniting an alliance with approximately 4,400 U.S. hospitals and health systems. Effective July 1st, the new agreement allows Premier members, at th
OpSens Inc. ("OpSens" or the "Company") (TSX: OPS) (OTCQX: OPSSF), a medical device cardiology-focused company delivering innovative solutions based on its proprietary optical technology, will report financial results for its third quarter of fiscal year 2022, ended May 31st, on Thursday, July 14, before the open of the market. The Company has scheduled a conference call the same day, at 11:00 AM ET, to review the results.